SCHEMBL7770587

SCHEMBL7770587

CCCC(N)C1(CC(=O)O)CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
CYP1A2 P05177 2/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.42
TSHR P16473 1/20 0.42
BLM P54132 1/20 0.42
CACNA2D1 P54289 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2C19 P33261 1/20 0.40
SLC1A2 P43004 3/20 0.33
SLC1A1 P43005 3/20 0.33
SLC1A3 P43003 2/20 0.33
GRIK1 P39086 2/20 0.33
GRIK2 Q13002 2/20 0.33
CHRM1 P11229 1/20 0.32
AKR1A1 P14550 1/20 0.32
CHRM3 P20309 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
ADRA1A P35348 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7764804 0.98 ALDH1A1 (0.41) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7764856 0.90 SLC1A2 (0.40) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7772817 0.86 CYP1A2 (0.44) ALDH1A1CYP1A2USP2LMNATSHR
Hydrochloric Acid SCHEMBL7764823 0.84 CYP1A2 (0.43) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL5608513 0.78 CYP1A2 (0.47) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL1077349 0.75 USP2 (0.33) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7770551 0.75 CYP1A2 (0.44) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7768488 0.75 CYP1A2 (0.44) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL7770014 0.75 TSHR (0.41) ALDH1A1CYP1A2USP2LMNATSHR
SCHEMBL4755028 0.74 USP2 (0.33) ALDH1A1CYP1A2USP2LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1157000-A1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER-LAMBERT COMPANY (US) 2001-11-28 EP claimed
WO-2001042191-A1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER-LAMBERT COMPANY (US) 2001-06-14 WO claimed
EP-1157000-A1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER-LAMBERT COMPANY (US) 2001-11-28 EP disclosed
WO-2001042191-A1 BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF DIABETIC RETINOPATHY WARNER-LAMBERT COMPANY (US) 2001-06-14 WO disclosed